Role of long non-coding RNAs in normal and malignant hematopoiesis

11Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Long non-coding RNAs (lncRNAs) are defined as a class of nonprotein-coding transcripts greater than 200 nucleotides in length, which have diverse functions in development and diseases including hematopoiesis. Recent advances have revealed that lncRNAs regulate hematopoietic development at almost every stage, including differentiation of the myelocyte, lymphocyte, and erythrocyte. Abnormal regulation of the lncRNAs may block aspects of blood development, which can lead to different types of hematopoietic disorders. These findings highlight the role of lncRNAs as potential therapeutic tools in malignant hematopoiesis. In this review, we summarize recent progress in the study of functional lncRNAs associated with blood development, as well as dysregulated lncRNAs involved in diverse blood diseases by interacting with crucial susceptibility genes in different pathways. In addition, we discuss genome-wide studies on lncRNAs, which are helpful for genome screening and in-depth functional study of lncRNAs associated with blood development and disease. © 2013 The Author(s).

Cite

CITATION STYLE

APA

Wei, P. P., Han, B. W., & Chen, Y. Q. (2013, October). Role of long non-coding RNAs in normal and malignant hematopoiesis. Science China Life Sciences. https://doi.org/10.1007/s11427-013-4550-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free